Eplerenone in Mild Heart Failure

被引:0
|
作者
Tomaschitz, Andreas [1 ]
Pilz, Stefan [1 ]
Maerz, Winfried [2 ]
机构
[1] Med Univ Graz, Graz, Austria
[2] Synlab Ctr Lab Diagnost Heidelberg, Heidelberg, Germany
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 364卷 / 14期
关键词
ALDOSTERONE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1371 / 1371
页数:1
相关论文
共 50 条
  • [21] Real world comparison of spironolactone and eplerenone in patients with heart failure
    Pardo-Martinez, Patricia
    Barge-Caballero, Eduardo
    Bouzas-Mosquera, Alberto
    Barge-Caballero, Gonzalo
    Couto-Mallon, David
    Paniagua-Martin, Maria J.
    Sagastagoitia-Fornie, Marta
    Prada-Delgado, Oscar
    Muniz, Javier
    Almenar-Bonet, Luis
    Vazquez-Rodriguez, Jose M.
    Crespo-Leiro, Maria G.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 97 : 86 - 94
  • [22] Population Pharmacokinetics of Eplerenone in Japanese Patients With Chronic Heart Failure
    Oishi, Masayo
    Tomono, Yoshiro
    Zhao, Qinying
    Sweeney, Kevin
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (06): : 730 - 738
  • [23] Eplerenone: hypertension, heart failure and the importance of mineralocorticoid receptor blockade
    Funder, John W.
    FUTURE CARDIOLOGY, 2006, 2 (05) : 535 - 541
  • [24] Eplerenone favourably alters collagen metabolism in diastolic heart failure
    Mak, G.
    Ledwidge, M.
    Murphy, N. F.
    Phelan, D.
    Dawkins, I.
    Watson, C.
    Baugh, J.
    Mcdonald, K.
    EUROPEAN HEART JOURNAL, 2009, 30 : 866 - 866
  • [25] Eplerenone in Patients With Acute Myocardial Infarction Complicated by Heart Failure
    Ramaraj, Radhakrishnan
    HYPERTENSION, 2008, 52 (06) : E147 - E147
  • [26] Selective aldosterone blockade with eplerenone in patients with congestive heart failure
    Salam, AM
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (08) : 1423 - 1427
  • [27] Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalemia
    Rossignol, P.
    Girerd, N.
    Bakris, G.
    Vardeny, O.
    Clagett, B.
    McMurray, J.
    Swedberg, K.
    Krum, H.
    Van Veldhuisen, D. J.
    Shi, H.
    Spanyers, S.
    Vincent, J.
    Fay, R.
    Lamiral, Z.
    Solomon, S.
    Zannad, F.
    Pitt, B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 5 - 5
  • [28] Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia
    Rossignol, Patrick
    Girerd, Nicolas
    Bakris, George
    Vardeny, Orly
    Claggett, Brian
    McMurray, John J. V.
    Swedberg, Karl
    Krum, Henry
    van Veldhuisen, Dirk J.
    Shi, Harry
    Spanyers, Sean
    Vincent, John
    Fay, Renaud
    Lamiral, Zohra
    Solomon, Scott D.
    Zannad, Faiez
    Pitt, Bertram
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (06) : 792 - 799
  • [29] Eplerenone: A selective aldosterone receptor antagonist for patients with heart failure
    Barnes, BJ
    Howard, PA
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (01) : 68 - 76
  • [30] Eplerenone: is it time to add this drug to current heart failure therapy?
    Pitt, Bertram
    Zannad, Faiez
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2012, 3 (01) : 5 - 9